Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis

PaperCitations, authors & open-access status

Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 13 citations, 2021 year and hybrid oa status.

13
Citations
2021
Year
hybrid
OA Status

Related on ScholarIQ

Erin Connolly-Strong
Author
Rheumatoid Arthritis Research and Therapies
Topic
Rheumatoid Arthritis Research and Therapies
Topic
Computational Drug Discovery Methods
Topic
Statistical Methods in Clinical Trials
Topic
470M+ articles · free account